Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Pentose Pharmaceuticals Inc
Profile last edited on: 1/5/2007      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1994
First Award
1998
Latest Award
1999
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

45 Moulton Street
Cambridge, MA 02138
   (617) 864-4800
   N/A
   www.pentose.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Pentose Pharmaceuticals discovers, develops and commercializes antiviral products for medical use based on nucleic acid chemistry. On 11/15/1999 Pentose Pharmaceuticals Inc merged with V.I.Technologies, Inc. (VITEX) .

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$299,500
Phase II Dollars
$0
Total Awarded
$299,500

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1999 1 NIH $100,000
Project Title: Virus Inactivation Of Human Red Cells For Transfusion
1999 1 NIH $100,000
Project Title: Viral Inactivation Of Intravenous Immunoglobulin (IVIG)
1998 1 NIH $99,500
Project Title: Virus Inactivation Of Human Blood Before Clinical Assays

Key People / Management

Company News

There are no news available.